Astra Zeneca

Rediff.com » News » Astra Zeneca

News for Astra Zeneca

News
Business

AstraZeneca's COVID-19 Vaccine: The TTS Factor

'It is admitted that the AZ vaccine can, in very rare cases, cause TTS.' IMAGE: A vial labelled 'AstraZeneca COVID-19 Vaccine'. Photograph: Illustration/Dado Ruvic/Reuters The controversial......

AstraZeneca withdraws COVID-19 vaccine globally: Report

United Kingdom-based pharmaceutical major AstraZeneca has started global withdrawal of its COVID-19 vaccine, which was provided in India as 'Covishield' in partnership with Serum Institute of......

AstraZeneca admits in court: Covishield causes TTS

United Kingdom-headquartered pharmaceutical giant AstraZeneca (AZ) has admitted that in 'very rare cases' its Covid vaccine can cause a blood clot related side effect but the causal link is......

AstraZeneca reaffirms Covid vaccine safety amid rare TTS concerns

In light of recent concerns surrounding potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant has reiterated its commitment to patient safety while......

Pfizer, AstraZeneca vaccines less effective against Delta

The COVID-19 vaccines by Pfizer and AstraZeneca are less effective against the Delta variant of coronavirus compared to the Alpha variant, according to a study led by researchers at the University......

AstraZeneca India to delist scrip

AstraZeneca Pharma India, the Indian subsidiary of AstraZeneca Pharmaceuticals AB, Sweden, has decided to delist its scrip from the Bombay Stock Exchange, National Stock Exchange and Bangalore......

AstraZeneca rejects Pfizer's final deal offer

Britain's AstraZeneca on Monday rejected a sweetened and "final" offer from Pfizer , casting serious doubt on the U.S. drugmaker's plan for a merger to create the world's biggest pharmaceuticals......

AstraZeneca reaches Ranbaxy settlement

Shares in AstraZeneca jumped more than 8 per cent in early trading on Tuesday as the Anglo-Swedish pharmaceutical group said it had agreed a long-term deal with Ranbaxy of India to end patent......

AstraZeneca to scale up Indian biz

AstraZeneca will scale-up its operations in India with the expansion of its Process R&D group in Bangalore.Announcing the expansion, Kumud Sampath, president, AstraZeneca Bangalore said, "It has......

AstraZeneca declares 35% dividend

AstraZeneca Pharma India 35 per cent dividend for fiancial year 2002.BSE code:...

Astra Zeneca

News for Astra Zeneca

AstraZeneca's COVID-19 Vaccine: The TTS Factor

AstraZeneca withdraws COVID-19 vaccine globally: Report

AstraZeneca admits in court: Covishield causes TTS

AstraZeneca reaffirms Covid vaccine safety amid rare TTS concerns

Pfizer, AstraZeneca vaccines less effective against Delta

AstraZeneca India to delist scrip

AstraZeneca rejects Pfizer's final deal offer

AstraZeneca reaches Ranbaxy settlement

AstraZeneca to scale up Indian biz

AstraZeneca declares 35% dividend

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS